Introduction: Lactococcus garvieae is a well-recognized fish pathogen, and it is considered a rare pathogen with low virulence in human infection. We describe the 11th case of L. garvieae infective endocarditis reported in the literature, and the first reported case in Japan.
Introduction
Lactococcus garvieae was first isolated from cases of bovine mastitis [1] , and it is rarely reported in human infection. The first human infection was documented as infective endocarditis (IE) in 1991 [2] . Since then, it has been identified as a pathogen in IE [3] [4] [5] [6] [7] [8] [9] , liver abscess [10] , and osteomyelitis [4] . We describe the 11th case of L. garvieae IE reported in the literature, and the first reported case in Japan.
Case presentation
A 55-year-old healthy Japanese woman presented to our hospital with a two-month history of malaise and myalgia, and she had had a fever for one month. The patient had no significant medical history and no relevant history regarding pets, travel, dental treatment, or drug abuse. Her occupational history was that she worked at an import grocery store. During her physical examination, we noted her body temperature of 37.6°C, a grade 2 systolic murmur at the apex, and a painful 1 mm black induration on her right forefinger. Trans-thoracic echocardiography showed a 1 cm mobile mass on the mitral valve with moderate mitral regurgitation. Her laboratory tests showed a white blood cell count of 8200/μL, a C-reactive protein level of 6.6 mg/dL, and a hemoglobin level of 9.9 g/dL. Gram-positive cocci forming pairs or short chains were shown by Gram staining of three sets of blood cultures drawn at the time of admission.
IE was diagnosed on the basis of the Duke criteria for the diagnosis of infective endocarditis [11] (two major and two minor criteria) and antibiotic treatment with benzylpenicillin 3 million units every four hours and gentamicin 60 mg every eight hours was started, as Streptococcus sp. was suspected as the causative pathogen. Subsequently, the rapid ID32 Strep (bioMérieux, Marcy-l'Etoile, France) profile (code 34323501010) revealed L. garvieae. We also performed molecular species identification by 16S ribosomal RNA gene (16S rRNA) sequencing, and the almost full-length 16S rDNA matched L. garvieae (99.9%). The results of an anti-microbial susceptibility test using Etest strips (AB Biodisk, Dalvagen, Solna, Sweden) showed the following values: erythromycin 0.25 mg/L, clindamycin ≥ 256 mg/ L, vancomycin 0.38 mg/L, linezolid 2.0 mg/L, penicillin 0.5 mg/L, ceftriaxone 0.38 mg/L, gentamicin 1.5 mg/L, and streptomycin 64 mg/L. Considering these results, we changed the anti-microbial treatment to intravenous ceftriaxone 2 g every 12 hours and gentamicin 80 mg every eight hours intraveneously.
Meanwhile, her body temperature rose to 39°C with left lower back pain on her sixth day in the hospital. Left-sided renal infarction was diagnosed on the basis of contrast-enhanced computed tomography (CT) ( Figure  1 ). On the 12th hospital day, cerebral infarction occurred, followed by a sudden onset of right-sided hemiparesis and slurred speech (National Institutes of Health Stroke Scale (NIHSS) score 12). Diffusionweighted MRI showed a cerebral infarction of the middle cerebral artery area (Figure 2) . Furthermore, cerebral mycotic aneurysms were detected by three-dimensional CT angiography on the 24th hospital day (Figure 3 ). The patient also developed aspiration pneumonia after the cerebral infarction complication.
Anti-microbial treatment was completed in nine weeks, including the treatment for pneumonia. Several repeat blood cultures thereafter were all negative. The vegetation on the mitral valve was no longer detected by trans-esophageal echocardiography performed just before she was discharged from the hospital. We found by CT that her left-sided renal infarction had improved, and the consequences of her cerebral infarction had also improved with only right-sided muscular weakness (NIHSS score 2). She was discharged from the hospital, and she is now well while being monitored in the outpatient clinic.
Discussion
Genus Lactococcus was separated from genus Streptococcus in 1985 based on DNA-DNA relatedness and 16S rRNA sequencing data published by Ludwig et al. [12] . The genus Lactococcus was classified into eight species literature [2] [3] [4] [5] [6] [7] [8] [9] . Five of ten cases involved native valves [3, [6] [7] [8] [9] , and four cases required surgery for valve replacement [3, 6, 8, 9] . In addition, two cases were complicated by cerebral infarction or hemorrhage [3, 9] . L. garvieae IE is uncommon; however, the virulence of L. garvieae might be underestimated. The treatment for L. garvieae IE is not standardized, because the exact criterion of the susceptibility test has not been established. In the published cases, penicillin combined with gentamicin, amoxicillin combined with netilmicin, ampicillin, ceftriaxone, and vancomycin were used as anti-microbial treatment. In our case, the results of the anti-microbial susceptibility test of the isolate using the Etest method was susceptibility to ceftriaxone (0.38 mg/L), erythromycin (0.25 mg/L), vancomycin (0.38 mg/L), and linezolid (2 mg/L), less susceptibility to penicillin (0.5 mg/L), and resistance to clindamycin (> 256 mg/L).
Elliott and Facklam [15] reported that clindamycin resistance is a feature of L. garvieae, and this feature can be used to distinguish it from other lactococci. To confirm the precise identification, various molecular techniques are available: whole-cell protein analysis, 16S rRNA gene sequencing, and sodA int (an internal fragment of the sodA gene encoding the manganese-dependent superoxide dismutase) gene sequencing.
L. garvieae has pathogenicity for several fish species, ruminants, and humans. Therefore, it could be a potentially zoonotic infection. Investigators in one recent report hypothesized that eating infected raw fish carrying L. garvieae caused its infection [7] . To investigate the relationship between our isolate and fish isolates, the immunological property was examined by using several anti-sera against L. garvieae that have previously been produced by fish in Japan. The results showed that our isolate did not have a capsule detected by any anti-capsule antibody for fish isolates. Pulsed-field gel electrophoresis also showed that the pattern of our isolate was quite different from that of fish-derived strains (data not shown). Vela et al. [16] found great phenotypic heterogeneity and genetic diversity among the L. garvieae isolates from fish, cows, water buffalo, and humans, with a generally good correlation between the phenotypic and genetic properties of L. garvieae. As the origin of the L. garvieae strain in our patient could not be clarified by the investigations used to detect Japanese fish pathogens, other causes of her infection, such as cow's milk or cheeses, are possible. To confirm the etiology of the transmission of L. garvieae, larger molecular epidemiological studies including investigating causes from the environment, animals, and humans must be carried out.
Conclusion
Herein we report the first case of L. garvieae IE in Japan. Molecular biological investigation techniques such as 16S ribosomal RNA gene sequencing are useful for the identification of L. garvieae. Although L. garvieae is considered a rare pathogen with low virulence in human infection, it could cause native valve endocarditis in healthy people. It might be necessary to review the precise estimation of the pathogenicity of L. garvieae.
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